Related Experiment Video

Updated: May 20, 2026

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models
05:33

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Published on: September 6, 2024

[Therapeutic approaches in Melanoma - a paradigm for personalized medicine]

R Dummer1, S Goldinger, J Rinderknecht

  • 1Dermatologische Klinik, Universitätsspital Zürich. reinhard.dummer@usz.ch

Praxis
|July 20, 2012
PubMed

Insights

Molecular biology advances enable melanoma subtype classification. Targeted therapies, like vemurafenib and interferon, offer personalized treatment for advanced melanoma based on genetic mutations and patient characteristics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Melanoma is recognized as a heterogeneous group of tumors.
  • Specific genetic alterations, including kinase mutations (e.g., B-RAF, c-kit), characterize different melanoma subtypes.

Purpose:

  • To highlight the advancements in melanoma classification and treatment.
  • To discuss the development of targeted therapies based on molecular profiling.

Summary:

  • Molecular biology progress has led to a new classification of melanomas based on distinct genetic alterations.
  • Systemic therapies, such as vemurafenib, are available for advanced melanomas with specific mutations (e.g., B-RAF).
  • Interferon therapy shows promise for patients with microscopic lymph node involvement and primary tumor ulceration.

Impact:

  • These developments represent initial steps toward personalized treatment strategies for melanoma patients.
  • Precision medicine approaches are transforming melanoma care by tailoring treatments to individual tumor molecular profiles.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...